AU4478096A - Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins - Google Patents

Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins

Info

Publication number
AU4478096A
AU4478096A AU44780/96A AU4478096A AU4478096A AU 4478096 A AU4478096 A AU 4478096A AU 44780/96 A AU44780/96 A AU 44780/96A AU 4478096 A AU4478096 A AU 4478096A AU 4478096 A AU4478096 A AU 4478096A
Authority
AU
Australia
Prior art keywords
composition
sesquiterpene lactone
riboflavin
complex vitamin
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44780/96A
Other languages
English (en)
Inventor
Natalie J Lazarowych
Michael O'connell
Peter Pekos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASHBURY RESEARCH Corp
Original Assignee
Ashbury Res Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ashbury Res Corp filed Critical Ashbury Res Corp
Publication of AU4478096A publication Critical patent/AU4478096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU44780/96A 1995-01-26 1996-01-25 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins Abandoned AU4478096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA2141126 1995-01-26
CA002141126A CA2141126A1 (fr) 1995-01-26 1995-01-26 Medicament d'association pour le traitement de la migraine et d'autres affections
PCT/CA1996/000052 WO1996022774A2 (fr) 1995-01-26 1996-01-25 Association medicamenteuse comprenant une sesquiterpene lactone et des vitamines du complexe b, destinee au traitement de la migraine et d'autres troubles

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU27755/00A Division AU2775500A (en) 1995-01-26 2000-04-13 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and B-complex vitamins

Publications (1)

Publication Number Publication Date
AU4478096A true AU4478096A (en) 1996-08-14

Family

ID=4155120

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44780/96A Abandoned AU4478096A (en) 1995-01-26 1996-01-25 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins

Country Status (6)

Country Link
EP (1) EP0805680A2 (fr)
JP (1) JPH10512573A (fr)
KR (1) KR19980701720A (fr)
AU (1) AU4478096A (fr)
CA (1) CA2141126A1 (fr)
WO (1) WO1996022774A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001513803A (ja) * 1997-03-03 2001-09-04 ラボラトワール ルミレア 植物抽出物組成物、その製造方法、及びそれを含む医薬組成物
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6068999A (en) * 1998-06-25 2000-05-30 Hendrix; Curt Dietary supplement for supporting cerebrovascular tone and treating migraine headaches
DE19844836A1 (de) * 1998-09-30 2000-04-20 Hexal Ag Pharmazeutisch, wirksames, pflanzliches Präparat zur Behandlung von Migräne
EP0951842B1 (fr) 1999-01-20 2002-12-04 N.V. Nutricia Aliment pour bébé
US6312736B1 (en) * 1999-12-09 2001-11-06 Biotech Corporation Herbal composition to relieve pain
US6890946B2 (en) 1999-12-23 2005-05-10 Indiana University Research And Technology Corporation Use of parthenolide to inhibit cancer
CA2406733A1 (fr) * 1999-12-23 2001-06-28 Harikrishna Nakshatri Utilisation du parthenolide pour inhiber le cancer
US7192614B2 (en) * 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
WO2008010335A1 (fr) * 2006-07-21 2008-01-24 Mmt Co., Ltd. Extrait végétal ayant un effet préventif sur l'arthrite
WO2008075649A1 (fr) * 2006-12-20 2008-06-26 Mmt Co., Ltd. Boisson, aliment, alicament, composition médicinale et procédé destinés à favoriser la croissance capillaire
JPWO2008075466A1 (ja) * 2006-12-20 2010-04-08 株式会社エム・エム・ティー 発毛促進用飲食物、医薬部外品、医薬組成物ならびに発毛促進方法
CN101278928B (zh) 2007-04-06 2011-09-07 常州高新技术产业开发区三维工业技术研究所有限公司 含左卡尼汀或其衍生物的药物组合物及其用途
US20100284986A1 (en) * 2009-05-06 2010-11-11 Kelleher Kevin J Compositions and methods for prevention and treatment of migraines
IT201700085185A1 (it) * 2017-07-26 2019-01-26 Cristalfarma S R L Integratore alimentare per uso come coadiuvante nel trattamento e profilassi dell’emicrania

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4173M (fr) * 1965-02-01 1966-05-23
CA1270843A (fr) * 1982-05-19 1990-06-26 Edward Stewart Johnson Lactones sesquiterpenes
US4542026A (en) * 1983-04-29 1985-09-17 Jose Rios Method of treating vasomotor disorders
JPS63303915A (ja) * 1987-06-05 1988-12-12 Nikko Sogyo Kk 養毛用組成物
DE3808141A1 (de) * 1988-03-11 1989-09-21 Mai Jutta Mittel zur bekaempfung von migraene
JPH0713021B2 (ja) * 1991-08-01 1995-02-15 文夫 堂園 消化器系疾患治療用内服薬剤
JPH05306231A (ja) * 1992-04-24 1993-11-19 Pola Chem Ind Inc 皮膚外用剤
WO1994001899A1 (fr) * 1992-07-02 1994-01-20 W. L. Gore & Associates, Inc. Chassis d'etancheite et membrane protectrice pour antenne de radar parabolique et a cornet

Also Published As

Publication number Publication date
JPH10512573A (ja) 1998-12-02
KR19980701720A (ko) 1998-06-25
WO1996022774A2 (fr) 1996-08-01
EP0805680A2 (fr) 1997-11-12
CA2141126A1 (fr) 1996-07-27
WO1996022774A3 (fr) 1996-09-26

Similar Documents

Publication Publication Date Title
AU4478096A (en) Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
US20060204599A1 (en) Dietary supplement and method of using same
JP2002518456A (ja) 脳血管の正常状態を支持するための栄養補助食品
JP2008501655A (ja) メロキシカム含有組成物
WO2005084392A2 (fr) Formulations a base de 4-methylpyrazole destinees a inhiber l'intolerance a l'ethanol
US4438138A (en) Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
JP3018160B2 (ja) 月経困難症及び／又は月経前症候群の軽減用薬剤
EA002166B1 (ru) Фармацевтическая композиция, содержащая трамадол - лекарственное средство для лечения мигрени
CZ289395A3 (en) Transdermic therapeutic system for administration of serotonin agonists
US5082665A (en) Anti-snoring formulations using yohimbine
JP2001518481A (ja) 経口投与のためのセロトニン含有製剤及びその使用方法
US4794112A (en) Acetaminophen/hydroxyzine analgesic combinations
US5011841A (en) Treatment of depression
US5026706A (en) Method for treating dysuria using naftopidil
Sjaastad et al. 2‐(2.6‐dichlorophenylamino)‐2‐imidazoline hydrochloride (ST 155 or Catapresan) as a prophylactic remedy against migraine
US20110117070A1 (en) Compositions and methods for treating headache
GB2248392A (en) Composition to combat alcoholism
US4515802A (en) Analgesic preparations
Ashida et al. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers
AU2775500A (en) Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and B-complex vitamins
Beaumont Clomipramine (Anafranil) in the treatment of pain, enuresis and anorexia nervosa
JPH04173741A (ja) 高血圧症予防・治療剤
GB2135884A (en) Analgesic preparations containing tizanidine and paracetamol
JPH0232020A (ja) モルフィン鎮痛治療における耐性発現の抑制方法および薬剤
US6416792B1 (en) Compositions comprising equisetum and symphytum and methods for the treatment of symptoms associated with mycoplasma infection

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted